Eurocine Vaccines operates in the pharmaceutical industry with a focus on developing vaccines for the global market. The company develops vaccine candidates from early innovation and licenses them to partners for further development and commercialization. The activities are carried out in the bioscience cluster at Karolinska Institutet in Solna, Sweden.

Quotes for Eurocine Vaccines AB

Right Now

+/-
-0.065
%
-4,59%
Latest
1.35
High
1.425
Low
1.25
Volume
117 427
Turnover (SEK)
159 248
Market Value (MSEK)
37,5
Time (Latest trade)
2023-02-03 17:29

Board

CEO

  • Hans Arwidsson

Chairperson of the Board

  • Pierre Morgon

Board

  • Carlos von Bonhorst
  • Emanuele Montomoli
  • Hans Arwidsson
  • Pär Thuresson

Videos

Largest Owners

Name Capital % Votes % Date
Thomas Eldered 28,71 28,71 2022-11-03
Avanza Pension 5,93 5,93 2022-12-28
Nordnet Pensionsförsäkring 2,10 2,10 2022-12-28
Kent Olsson 1,43 1,43 2022-12-28
Göran Erlandsson 1,28 1,28 2022-12-28
Mats Kenneth Pettersson 1,01 1,01 2022-12-28
Bo Sjögren 0,85 0,85 2022-12-28
VisMederi Srl 0,79 0,79 2022-10-20
Stig Andreas Lööf 0,78 0,78 2022-12-28
Johann Bech Vedsmand 0,74 0,74 2022-12-28
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2023-02-28 Delårsrapport 2023-Q2

  • 2023-05-24 Delårsrapport 2023-Q3

  • 2023-08-30 Bokslutskommuniké 2023